Seeing Is Believing

Currently out of the existing stock ratings of Tyler Van Buren, 219 are a BUY (79.35%), 53 are a HOLD (19.2%), 4 are a SELL (1.45%).
Analyst Tyler Van Buren, currently employed at TD COWEN, carries an average stock price target met ratio of 44.61% that have a potential upside of 29.22% achieved within 300 days.
Tyler Van Buren’s has documented 554 price targets and ratings displayed on 60 stocks. The coverage is on Healthcare, Communication Services, Consumer Defensive, Technology sectors.
Most recent stock forecast was given on BBIO, BridgeBio Pharma at 11-Aug-2026.
Analyst best performing recommendations are on IONS (IONIS PHARMACEUTICALS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 3/22/2021. The price target of $45 was fulfilled within 1 day with a profit of $10.64 (19.12%) receiving and performance score of 191.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
10 months 14 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 28-Apr-2020
$5.5
$1.14 (26.15%)
$12
11 months 2 days ago
(29-Oct-2025)
2/10 (20%)
$1.27 (30.02%)
511
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
11 months 3 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 1 months 18 days ago
(13-Aug-2025)
1/3 (33.33%)
$30.52 (321.94%)
243
Hold Since 11-Nov-2022
$4
$-0.36 (-8.26%)
$5
1 years 4 months 16 days ago
(15-May-2025)
3/7 (42.86%)
$1.95 (95.12%)
321
Which stock is Tyler Van Buren most bullish on?
Which stock is Tyler Van Buren most reserved on?
What Year was the first public recommendation made by Tyler Van Buren?